ArticleFrontiers in pharmacology2024

Model informed dose regimen optimizing in development of leritrelvir for the treatment of mild or moderate COVID-19.

Kun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.